Moreover, KIOM-C and Ganoderma lucidum have been shown to abrogate the metastatic potential of malignant HT1080 cells and reduce ovarian cancer cell growth by reducing MMP activity via the suppression of NF-κB activation and downregulation of VEGF expression, respectively [30–32]. This evidence concerns the gene NFKB1 and ovarian carcinoma.